BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Exicure (XCUR)’s GPC-100 Could Revolutionize Cancer Treatment – Analysts See Massive Upside for this Stock!

    Exicure, Inc. (NASDAQ:XCUR) is a biotechnology company that has undergone a significant…
    BioTech Health X
    • August 3, 2025
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    DRMA Stock Alert – Why Dermata Therapeutics (DRMA) Could Be the Hidden Biotech Gem of 2025!

    • BioTech Health X
    • August 3, 2025

    Fulcrum Therapeutics (FULC)’s Stunning Trial Results Could Make it the Next Biotech Breakout!

    • BioTech Health X
    • August 3, 2025

    FDA Decision Looms for LENZ Therapeutics (LENZ) – Analysts Predict a Huge Breakout

    • BioTech Health X
    • August 3, 2025

    FDA Approval Could Send Tonix Pharmaceuticals (TNXP) Soaring – Don’t Miss Out

    • BioTech Health X
    • August 3, 2025

    Most Trending
    Stories

    Biotech NewsExicure (XCUR)’s GPC-100 Could Revolutionize Cancer Treatment – Analysts See Massive Upside for this Stock!

    • BioTech Health X
    • August 3, 2025

    Biotech NewsDRMA Stock Alert – Why Dermata Therapeutics (DRMA) Could Be the Hidden Biotech Gem of 2025!

    • BioTech Health X
    • August 3, 2025

    Biotech NewsFulcrum Therapeutics (FULC)’s Stunning Trial Results Could Make it the Next Biotech Breakout!

    • BioTech Health X
    • August 3, 2025

    Biotech NewsFDA Decision Looms for LENZ Therapeutics (LENZ) – Analysts Predict a Huge Breakout

    • BioTech Health X
    • August 3, 2025

    Biotech NewsFDA Approval Could Send Tonix Pharmaceuticals (TNXP) Soaring – Don’t Miss Out

    • BioTech Health X
    • August 3, 2025

    Exicure (XCUR)’s GPC-100 Could Revolutionize Cancer Treatment – Analysts See Massive Upside for this Stock!

    • BioTech Health X
    • August 3, 2025
    Exicure, Inc. (NASDAQ:XCUR) is a biotechnology company that has undergone a significant strategic transformation to focus on advancing…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    DRMA Stock Alert – Why Dermata Therapeutics (DRMA) Could Be the Hidden Biotech Gem of 2025!

    • BioTech Health X
    • August 3, 2025
    Dermata Therapeutics, Inc. (NASDAQ:DRMA) is a clinical-stage biotechnology company focused on developing innovative and differentiated therapies for dermatological…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Fulcrum Therapeutics (FULC)’s Stunning Trial Results Could Make it the Next Biotech Breakout!

    • BioTech Health X
    • August 3, 2025
    Fulcrum Therapeutics Inc. (NASDAQ:FULC) is a clinical-stage biopharmaceutical company dedicated to developing small-molecule therapies that target the root…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    FDA Decision Looms for LENZ Therapeutics (LENZ) – Analysts Predict a Huge Breakout

    • BioTech Health X
    • August 3, 2025
    LENZ Therapeutics Inc. (NASDAQ:LENZ) is a clinical-stage biopharmaceutical company dedicated to addressing a significant unmet need in ophthalmology…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    FDA Approval Could Send Tonix Pharmaceuticals (TNXP) Soaring – Don’t Miss Out

    • BioTech Health X
    • August 3, 2025
    Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies that address significant…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    The Secret Wall Street Play: Why Big Money Is Buying Johnson & Johnson (JNJ)

    • BioTech Health X
    • August 3, 2025
    Johnson & Johnson (NYSE:JNJ) is one of the world’s most iconic and diversified healthcare companies, with a history…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    ADMA Biologics (ADMA) Could Be the Next Billion-Dollar Biotech Superstar

    • BioTech Health X
    • August 3, 2025
    ADMA Biologics Inc. (NASDAQ:ADMA) is a fast-growing biopharmaceutical company focused on the development, manufacturing, and commercialization of specialty…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Novo Nordisk (NVO) Crashes – Is This the Biggest Buying Opportunity of 2025?

    • BioTech Health X
    • August 3, 2025
    Novo Nordisk A/S (NYSE:NVO) is a global healthcare leader headquartered in Denmark, renowned for its pioneering work in…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    4D Molecular (FDMT): The Gene Therapy Stock With 100%+ Upside Potential

    • BioTech Health X
    • August 1, 2025
    4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) is a clinical-stage biotechnology company dedicated to developing next-generation gene therapies using its…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Bio-Rad Labs (BIO) Smashes Earnings Estimates – Is the Stock Ready to Explode?

    • BioTech Health X
    • August 1, 2025
    Bio-Rad Laboratories Inc. (NYSE:BIO) is a global leader in life science research and clinical diagnostics, known for its…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Performant Healthcare (PHLT) Gets $670M Buyout – Could This Be the Smartest Trade of 2025?

    • BioTech Health X
    • August 1, 2025
    Performant Healthcare Inc. (NASDAQ: PHLT) is a leading provider of technology-enabled payment integrity, eligibility, and analytics services for the…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Wall Street Doesn’t Want You to See This Stock – Quantum (QNTM) Could Be the Next Jackpot

    • BioTech Health X
    • August 1, 2025
    Quantum BioPharma Ltd. (NASDAQ:QNTM) is a biopharmaceutical company focused on developing innovative therapies for neurodegenerative and metabolic disorders,…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Harmony Biosciences (HRMY) Could Double – The Shocking Analyst Targets You Need to See

    • BioTech Health X
    • July 31, 2025
    Harmony Biosciences Holdings, Inc. is a U.S.-based commercial-stage pharmaceutical company focused on developing and delivering innovative therapies for…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Acelyrin (SLRN) is Exploding in 2025 – Is SLRN the Hottest Biotech Play Right Now?

    • BioTech Health X
    • July 31, 2025
    Acelyrin, Inc. is a biotechnology company headquartered in California that focuses on developing innovative immunology-based therapies to address…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Kiniksa Pharmaceuticals (KNSA) is Breaking Out

    • BioTech Health X
    • July 31, 2025
    Kiniksa Pharmaceuticals International PLC is a global biopharmaceutical company dedicated to discovering, developing, and commercializing therapies for patients…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Analysts Are Bullish: Could Aurinia (AUPH) Be the Next Billion-Dollar Biotech Winner?

    • BioTech Health X
    • July 31, 2025
    Aurinia Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies for the treatment of…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    From $10 to $23? Why Niagen Bioscience (NAGE) Could Be the Next Big Biotech Success Story

    • BioTech Health X
    • July 28, 2025
    Niagen Bioscience Inc. (NASDAQ:NAGE) is a pioneering life sciences company that has become a global leader in the…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0

    Wall Street Is Going Crazy Over UroGen Pharma (URGN) – Here’s Why it Could Be a 2025 Winner

    • BioTech Health X
    • July 28, 2025
    UroGen Pharma Ltd. is a biotechnology company focused on developing and commercializing innovative therapies for urothelial and specialty…
    Read More
    0 Shares
    0
    0
    0
    0
    0
    0
    0
    Recent Posts
    • Exicure (XCUR)’s GPC-100 Could Revolutionize Cancer Treatment – Analysts See Massive Upside for this Stock!
    • DRMA Stock Alert – Why Dermata Therapeutics (DRMA) Could Be the Hidden Biotech Gem of 2025!
    • Fulcrum Therapeutics (FULC)’s Stunning Trial Results Could Make it the Next Biotech Breakout!
    • FDA Decision Looms for LENZ Therapeutics (LENZ) – Analysts Predict a Huge Breakout
    • FDA Approval Could Send Tonix Pharmaceuticals (TNXP) Soaring – Don’t Miss Out
    Recent Comments
    • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
    • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
    • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
    • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
    Featured Posts
      • August 3, 2025
      Exicure (XCUR)’s GPC-100 Could Revolutionize Cancer Treatment – Analysts See Massive Upside for this Stock!
      • August 3, 2025
      DRMA Stock Alert – Why Dermata Therapeutics (DRMA) Could Be the Hidden Biotech Gem of 2025!
      • August 3, 2025
      Fulcrum Therapeutics (FULC)’s Stunning Trial Results Could Make it the Next Biotech Breakout!
      • August 3, 2025
      FDA Decision Looms for LENZ Therapeutics (LENZ) – Analysts Predict a Huge Breakout
      • August 3, 2025
      FDA Approval Could Send Tonix Pharmaceuticals (TNXP) Soaring – Don’t Miss Out
    Recent Posts
    • Cel-Sci (CVM) Could Skyrocket 3,000% – Here’s Why Investors Are Buzzing
      • July 28, 2025
    • FDA Decision Incoming! Apellis Pharmaceuticals (APLS) Could Be the Next 10X Biotech Stock!
      • July 28, 2025
    • From NeuroBo to MetaVia (MTVA): This Biotech Just Went All-In on Obesity and Liver Disease
      • July 23, 2025
    Categories
    • BioTech CEO Interviews (9)
    • Biotech Info (1)
    • Biotech News (283)
    • Uncategorized (1)
    Author
    Hello, I’m
    BioTech Health X
    Follow
    BioTech Health X
    Designed & Developed by BioTech Health X
    • About BioTech Health X
    • List of Modern Life Science Technologies
    • Biotechnology Company Directory – List of Major Biotech Companies
    • Contact Us
    • Privacy Policy

    Subscribe to
    Our Updates

    Back to top